Other namesTypes of corneal endothelial dystrophyCausesSymptomsDiagnostic testsGoals of treatment in dystrophy of the corneal endotheliumNon-pharmacological treatmentsDrug treatmentsDietary molecular supplementsImmunity-booster, regenerative, and stem-cell–related therapiesSurgical treatmentsPrevention and lifestyle tipsWhen to see doctorsWhat to eat and what to avoidFrequently asked questionsDystrophy of the corneal endothelium is a long-lasting (chronic) disease of the inner layer of the clear front window of the eye, called the cornea. In this condition, the special pump cells in this inner layer (endothelial cells) slowly become sick and die. They can no longer remove extra water from the cornea. The cornea then becomes thick, swollen, and cloudy, which can cause blurred vision, glare, and sometimes pain. Most forms are inherited (run in families) and are not caused by infection. They usually get worse slowly over many years. ScienceDirect+1Dystrophy of the corneal endothelium is a long-term eye disease where the innermost cell layer of the cornea (the clear “front window” of the eye) slowly becomes weak, sick, or dies earlier than it should. The most common type is Fuchs endothelial (corneal) dystrophy, but there are other types too. In these diseases, the pump cells on the back of the cornea stop working properly, fluid builds up, the cornea swells, and vision becomes cloudy or hazy, especially in the morning.NCBI+1Over time, the swollen cornea can form tiny blisters on its surface. These blisters can burst and cause pain, light sensitivity, tearing, and a feeling that something is in the eye. In advanced stages, scarring can develop and vision may stay blurred all day. Many patients are older adults, and there is often a family history, which means genes play an important role in this disease.NCBI+1Other namesDystrophy of the corneal endothelium is often known by several other names, depending on the exact type. Common names include Fuchs endothelial corneal dystrophy (FECD), Fuchs dystrophy, endothelial corneal dystrophy, posterior polymorphous corneal dystrophy (PPCD), congenital hereditary endothelial dystrophy (CHED), and X-linked endothelial corneal dystrophy (XECD). All of these conditions mainly affect the endothelial cell layer and lead to similar problems with corneal swelling and cloudy vision, but they differ in age at onset, severity, and genetic cause. JSciMed Central+1The corneal endothelium is a single, very thin sheet of hexagon-shaped cells lining the inner surface of the cornea. These cells act like tiny pumps. They pull fluid out of the cornea and keep it clear and “dehydrated enough” to stay transparent. Unlike many other cells in the body, endothelial cells almost never divide or regrow. When they are lost, the neighboring cells spread out and become larger and irregular in shape. If too many cells are lost, the pump system fails, fluid builds up, and the cornea becomes thick and cloudy. This is the basic problem in all forms of corneal endothelial dystrophy. ScienceDirect+1Types of corneal endothelial dystrophyThere are several main types of corneal endothelial dystrophy. Doctors usually classify them by where in the cornea they occur and by the gene changes involved: corneasociety.org+2PMC+2Fuchs endothelial corneal dystrophy (FECD) – The most common type. It usually starts in middle age or later. It causes tiny bumps called guttae on the inner surface of the cornea and slow loss of endothelial cells.Posterior polymorphous corneal dystrophy (PPCD) – Often begins earlier in life. The back of the cornea shows patterns that can look like blisters, bands, or tracks.Congenital hereditary endothelial dystrophy (CHED) – Present from birth or early childhood. The cornea is cloudy very early in life because the endothelium does not work properly from the start.X-linked endothelial corneal dystrophy (XECD) – A rare form linked to the X chromosome, mostly affecting males, with early-onset endothelial changes.Mixed or overlapping forms – Some people show features of more than one type, and ongoing genetic research continues to refine the classification.All these types share the same final problem: not enough healthy endothelial cells to keep the cornea clear. JSciMed Central+2Europe PMC+2CausesBelow are 20 important causes and risk factors related to dystrophy of the corneal endothelium. Some are true “causes” (such as gene changes), and others are factors that make the disease more likely or more severe.Genetic mutations in the TCF4 geneIn many patients with Fuchs endothelial corneal dystrophy, there is a repeat expansion (extra copies of a three-letter DNA sequence, CTG) inside the TCF4 gene. This abnormal repeat is strongly linked to the disease and is now known to be one of the main genetic causes, especially in people of European ancestry. PubMed+2Nature+2Other endothelial dystrophy genesGene changes in COL8A2, SLC4A11, ZEB1, and other genes can cause or contribute to forms like early-onset Fuchs dystrophy, CHED, and PPCD. These genes are important for the structure of the Descemet membrane and the health of endothelial cells. JSciMed Central+1Family history of corneal dystrophyMany endothelial dystrophies are inherited in an autosomal dominant or recessive pattern. This means that if a parent is affected, their children have a higher chance of developing the disease. A clear family history is one of the strongest clues that genetics are involved. Cleveland Clinic+1Older ageFuchs dystrophy is strongly age-related. It is more common in people over 50 years old and becomes much more frequent in the elderly. Over time, natural cell loss plus the underlying genetic problem leads to visible disease. Cleveland Clinic+1Female sexMany studies show that Fuchs dystrophy is more common and often more severe in women than in men. The exact reason is not fully clear, but hormonal factors and differences in genetics and environment may play a role. Dove Medical Press+1Oxidative stress and cell damageEndothelial cells are exposed to light and oxygen all the time. Harmful molecules called reactive oxygen species can damage the cells. In Fuchs dystrophy, there is evidence of increased oxidative stress and reduced cell defense, which may speed up cell death. NCBI+1Thickening and abnormal structure of Descemet membraneIn many patients, the basement membrane under the endothelium (Descemet membrane) becomes unusually thick and irregular. This abnormal tissue makes it harder for endothelial cells to attach and function well, adding to their stress and loss. Dove Medical Press+1Corneal guttae formationGuttae are small, wart-like bumps on the inner corneal surface. They are a hallmark sign of Fuchs dystrophy. They reflect abnormal secretion of material from endothelial cells and often appear before the patient notices symptoms. Over time, they disrupt the normal cell layer. EyeWiki+2WebEye+2Prior eye surgery (especially cataract surgery)Eye surgery can damage endothelial cells, especially if the cornea is already fragile. In people with early or silent Fuchs dystrophy, cataract surgery may speed up endothelial cell loss and bring on swelling and vision problems sooner. NCBI+1Previous eye traumaA strong blow or penetrating injury to the eye can damage the corneal endothelium. If the eye already has a genetic tendency to cell loss, trauma may lead to earlier or more severe dystrophy. NCBI+1Intraocular inflammationLong-standing inflammation inside the eye (uveitis or chronic irritation) can harm endothelial cells. Over time, this may mimic or worsen an underlying dystrophy and lead to more rapid corneal decompensation. ScienceDirect+1High intraocular pressure (glaucoma)Elevated eye pressure can press on the corneal endothelium and stress the cells. People with both glaucoma and endothelial dystrophy are at higher risk of endothelial failure and corneal edema. ScienceDirect+1Diabetes and metabolic diseaseDiabetes and other metabolic diseases may affect small blood vessels, nerves, and cell metabolism. Some research suggests that diabetes is associated with thicker corneas and altered endothelial cell counts, which could worsen the course of dystrophy. NCBI+1SmokingSmoking increases oxidative stress and reduces blood supply. It has been associated with more rapid progression of several eye diseases and may worsen endothelial cell loss in people with Fuchs dystrophy. NCBI+1Chronic ultraviolet (UV) light exposureUV light can generate free radicals and damage corneal tissue. Over many years, high UV exposure may add to oxidative stress on endothelial cells and contribute to disease progression in susceptible individuals. NCBI+1Contact lens over-wearWearing contact lenses for long hours reduces oxygen reaching the cornea and may disturb the corneal surface and endothelium. In someone with a weak endothelium, this can lead to earlier swelling and blurred vision. ScienceDirect+1Abnormal eye anatomy (short or shallow eyes)Certain eye shapes, such as shallow anterior chambers, can make surgery and internal fluid flow more stressful for the endothelium. These anatomical factors may increase vulnerability in people with endothelial dystrophy. NCBI+1Endothelial-epithelial dystrophy variantsSome patients have combined endothelial and epithelial dystrophies, where abnormal fluid handling and cell behavior at both the back and front of the cornea add to chronic swelling and structural changes. Eco-Vector Journals Portal+1Rare systemic genetic syndromesA few rare hereditary syndromes that affect connective tissue or collagen can involve the cornea and lead to combined endothelial and stromal changes, increasing the risk of endothelial dystrophy-like damage. JSciMed Central+1Unknown or idiopathic factorsIn some patients, even after full testing, no clear trigger is found beyond age and mild genetic risk. In these cases, the dystrophy is called idiopathic, meaning that the exact cause is unknown but is likely due to a mix of genes and environment. Dove Medical Press+1SymptomsHere are 15 common symptoms seen in dystrophy of the corneal endothelium. Not everyone has all of them, and they usually worsen slowly over time.Blurred or hazy visionAs fluid builds up in the cornea and it becomes swollen, light cannot pass through clearly. Vision looks foggy or out of focus, even with glasses. This is the main symptom of endothelial dystrophy. EyeWiki+1Blurred vision worse in the morningMany patients say their vision is worse when they first wake up. During sleep, the eyelids are closed, less fluid evaporates, and the cornea swells more. As the day goes on and the eyes are open, some swelling goes down and vision improves. EyeWiki+1Glare from lightsSwollen and uneven corneal surfaces scatter light, causing bright halos or rings around headlights, streetlights, and other strong light sources. This can make driving at night difficult. EyeWiki+1Halos around lightsMany people notice colored circles or halos around lights. This happens because light rays are bent in an irregular way as they pass through the swollen cornea. EyeWiki+1Fluctuating vision during the dayVision may change hour to hour as corneal swelling changes. Some patients have relatively good vision at certain times and much worse vision at other times, even without changing glasses. Cleveland Clinic+1Poor contrast sensitivityPeople may say that everything looks “washed out” or “low contrast.” It becomes hard to see faces clearly in dim lighting or to read gray text on a slightly darker background. Dove Medical Press+1Difficulty with night drivingGlare, halos, and poor contrast make night driving especially challenging. Oncoming headlights can be very dazzling and may force patients to slow down or avoid driving at night. EyeWiki+1Foreign body sensationWhen small blisters (bullae) form on the corneal surface and break, the surface becomes rough. This can feel like sand, dust, or a hair in the eye, even when nothing is there. EyeWiki+1Eye pain or sharp discomfortRupture of corneal bullae exposes nerve endings, which can cause sharp pain, tearing, and light sensitivity. Pain can be severe in advanced disease, especially when blisters repeatedly form and break. WebEye+1Redness and tearingIrritation from a rough corneal surface and pain from bullae can lead to red, watery eyes. Some patients also squeeze their eyelids tightly because of discomfort, which can increase tearing. EyeWiki+1Light sensitivity (photophobia)Swollen and damaged corneas can be very sensitive to light. Even indoor light or a computer screen may feel too bright, and patients may wear sunglasses more often. EyeWiki+1Slow recovery after eye surgeryPeople with endothelial dystrophy may have more swelling and slower visual recovery after cataract surgery or other eye operations. They might notice that their vision stays blurry longer than expected. NCBI+1Reduced best-corrected vision with glassesEven with the “right” glasses prescription, vision can remain poor because the main problem lies in the cornea, not in the focusing power of the eye. This is a key sign that optical correction alone is not enough. Cleveland Clinic+1Increasing dependence on brighter light to readMany patients need very bright light or magnifiers to read small print, even if their eye exam shows reasonable visual acuity. This is related to loss of contrast and clarity from the cloudy cornea. Cleveland Clinic+1Progressive vision loss over yearsWithout treatment, endothelial dystrophy often worsens slowly. Over years, some patients can lose a large amount of vision, and in advanced cases, a corneal transplant may be needed to restore sight. Cleveland Clinic+1Diagnostic testsDoctors use a mix of clinical examination, simple office tests, imaging tests, and sometimes lab or genetic tests to diagnose endothelial corneal dystrophy. Key tools include slit-lamp biomicroscopy, corneal thickness measurement (pachymetry), and specular or confocal microscopy to look at endothelial cells. In selected cases, genetic testing and tissue studies can confirm the exact type of dystrophy. PLOS+4NCBI+4PMC+4Below, the tests are grouped into Physical Exam, Manual tests, Lab and Pathological, Electrodiagnostic, and Imaging. The total number of tests described is 20.Physical examination testsComprehensive eye examination and historyThe eye doctor first listens to the patient’s story: when blur started, whether it is worse in the morning, and any family history of similar problems. They then examine the eyes with a light, look at the eyelids, and check for redness or tearing. This basic exam helps decide which detailed tests are needed and often suggests corneal dystrophy early. EyeWiki+2Cleveland Clinic+2Visual acuity testing (eye chart)The patient reads letters on a chart at distance and near. This measures how clearly they can see. In endothelial dystrophy, vision is often reduced, and the pattern of blur (for example, worse in the morning) gives a clue that the cornea, not just the glasses power, is the problem. Cleveland Clinic+1External eye and corneal surface inspectionWith a bright light and magnification, the doctor inspects the front of the eye for signs of corneal clouding, surface roughness, and small blisters. Early swelling may appear as a slight loss of normal corneal sparkle; advanced disease shows more obvious haze. EyeWiki+1Corneal sensitivity and reflex testingThe doctor may gently touch the cornea with a fine cotton wisp or similar tool to see how sensitive it is and to test the blink reflex. Abnormal sensitivity may point to other corneal diseases, helping to separate dystrophy from conditions like severe dry eye or infections. ScienceDirect+1Fluorescein staining at the slit lampA drop of fluorescent dye (fluorescein) is placed on the eye. Under blue light at the slit lamp, areas where the surface layer is damaged or bullae have burst will glow. This helps show where the cornea is fragile and how severe the surface problem is. EyeWiki+1Manual testsApplanation tonometry (eye pressure measurement)The doctor uses a small device that gently touches the cornea to measure intraocular pressure. It may require a drop of anesthetic and fluorescein. High pressure (glaucoma) can worsen endothelial damage, so it is important to know the pressure in patients with corneal dystrophy. ScienceDirect+1Pinhole testLooking through a small pinhole in front of the eye helps decide whether blur is mainly from refractive error or from a corneal or retinal problem. In endothelial dystrophy, pinhole often does not fully clear the vision, suggesting that the cornea itself is the major cause of blur. Cleveland Clinic+1Tear film tests (Schirmer test and tear break-up time)Simple tear tests use small paper strips or dye to measure tear production and stability. While not specific for dystrophy, they help rule out dry eye as the main cause of symptoms and may show that dry eye and dystrophy are both present, making vision worse. ScienceDirect+1Glare and contrast sensitivity testingSpecial charts or devices can measure how well a person sees in glare and at different contrast levels. Patients with endothelial dystrophy often show reduced performance compared with their basic eye-chart vision, confirming the functional impact of corneal clouding. Dove Medical Press+1Lab and pathological testsCorneal endothelial cell count and morphology reportAlthough the images come from specular or confocal microscopy, the data (endothelial cell density, cell size variation, and shape changes) are often printed or stored as a report. Low cell counts and abnormal shapes confirm endothelial failure and help grade severity. PMC+2EyeRounds+2Corneal thickness measurement report (pachymetry)Corneal thickness can be measured by ultrasound or optical devices. A thicker than normal cornea suggests edema (swelling) and supports the diagnosis of advanced endothelial dystrophy. Serial measurements help track disease progression and treatment response. NCBI+2PLOS+2Genetic testing for endothelial dystrophy genesBlood or saliva samples can be analyzed for known gene changes, such as CTG repeat expansion in TCF4 or mutations in SLC4A11, COL8A2, and ZEB1. Positive results confirm the genetic nature of the disease and may guide family counseling. PubMed+2JSciMed Central+2Histopathology of corneal tissue (after transplant)When a diseased cornea is removed during transplant surgery, it can be examined under the microscope. Pathologists see features like thickened Descemet membrane, guttae, and loss of endothelium, which confirm the exact type and stage of dystrophy. PMC+2Dove Medical Press+2Electrodiagnostic testsVisual evoked potential (VEP)VEP measures electrical activity in the brain in response to visual stimuli. It is rarely needed for pure corneal dystrophy, but it can be useful if doctors suspect that part of the vision loss comes from optic nerve or brain problems rather than only the cornea. Normal VEP results support the idea that the main issue is in the cornea. ScienceDirect+1Electroretinogram (ERG)ERG records electrical responses from the retina. Like VEP, it is not a routine test for endothelial dystrophy, but it can rule out retinal diseases when the clinical picture is confusing. If ERG is normal but vision is poor and the cornea is cloudy, the dystrophy is likely the main cause. ScienceDirect+1Electro-oculogram (EOG)EOG measures the electrical potential across the eye during eye movements. It mainly helps in diagnosing diseases of the retinal pigment epithelium. In difficult cases, a normal EOG can support the conclusion that the visual problem is corneal, not retinal, which is important in planning treatment. ScienceDirect+1Imaging testsSlit-lamp biomicroscopy of the corneaSlit-lamp biomicroscopy is the main imaging-type examination for endothelial dystrophy. With a special microscope and a thin beam of light, the doctor can see guttae, corneal edema, folds in Descemet membrane, and epithelial bullae. This test is central to diagnosis and staging. NCBI+2EyeWiki+2Specular microscopySpecular microscopy is a non-invasive test that takes high-magnification images of the endothelial cell layer. It shows cell shape, size, and density and can visualize guttae. It is very helpful for confirming the diagnosis and monitoring progression over time. PMC+2EyeRounds+2In vivo confocal microscopyConfocal microscopy uses a laser to capture detailed images of corneal layers at a microscopic level. It can show endothelial cell dropout, guttae, and changes in other layers, providing a more complete picture of the disease and helping research into new treatments. PMC+2WebEye+2Anterior segment optical coherence tomography (AS-OCT)AS-OCT uses light waves to create cross-section images of the front of the eye. It shows corneal thickness and structure and can demonstrate edema, folds, and interface quality after corneal transplant. It is useful in diagnosis, planning surgery, and following patients after treatment. MDPI+2PLOS+2Goals of treatment in dystrophy of the corneal endotheliumThe main goals of treatment are to reduce corneal swelling, improve vision, decrease pain, protect the cornea from further damage, and delay or avoid the need for corneal transplant surgery when possible. Early in the disease, treatment focuses on symptom relief, like reducing morning blur and discomfort. Later, treatment focuses more on surgery to replace the damaged endothelial layer with healthy tissue.NCBI+1Treatment is usually step-by-step. Doctors often start with simple non-pharmacological therapies such as lifestyle changes and eye protection. If symptoms continue, they may add eye drops, ointments, or contact lenses. When blurry vision seriously affects daily life, or when the cornea becomes permanently scarred, surgery such as endothelial keratoplasty (DMEK or DSAEK) is usually recommended as the gold-standard treatment.PubMed+2aaojournal.org+2Non-pharmacological treatmentsWarm air or hair-dryer technique in the morningIn many people with Fuchs dystrophy, the cornea is most swollen on waking. Gently blowing warm (not hot) air across closed eyelids with a hair-dryer held at arm’s length for a few minutes can help evaporate extra fluid from the cornea. This simple home method can reduce morning blur and make vision clearer for daily activities. Always keep the dryer far enough away to avoid heat injury.Medscape eMedicine+1Avoiding smoky, dusty, and very dry airIrritants like cigarette smoke, air pollution, and very dry air can worsen corneal surface irritation and make symptoms such as burning, tearing, and light sensitivity worse. Keeping the home smoke-free, using a humidifier in dry rooms, and avoiding sitting directly under air-conditioner vents can protect the already fragile corneal surface and reduce discomfort over time.aao.org+1Protective sunglasses outdoorsWearing large, wrap-around UV-blocking sunglasses in bright sunlight helps reduce glare, squinting, and light sensitivity. It also protects the cornea from ultraviolet light, wind, and dust. This can make it more comfortable to be outside and may reduce micro-trauma to the corneal surface, which is important when the cornea is already swollen or blistered.aao.org+1Moisture chamber glasses or gogglesSome patients benefit from special glasses or goggles that trap moisture around the eye. These “moisture chambers” reduce evaporation of tears and may ease surface dryness and pain from tiny corneal blisters. They are especially helpful in air-conditioned offices, on airplanes, or in windy environments where the eyes dry out quickly.Medscape eMedicine+1Cold compresses for pain and swellingPlacing a clean, cold, damp cloth over closed eyes can temporarily reduce pain, redness, and swelling. The cooling effect may calm nerve endings in the cornea and eyelids and provide short-term relief without drugs. Compresses should be clean to reduce infection risk and should not be frozen, which could damage the delicate corneal surface.aao.org+1Bandage soft contact lensesIn patients with painful corneal blisters (bullae), doctors sometimes fit a special soft “bandage” lens. This lens protects the corneal surface from the rubbing of the eyelid and decreases pain. It does not fix the underlying endothelial problem but can greatly improve comfort while other treatments, such as drops or surgery, are being planned. Proper cleaning and follow-up are essential to avoid infection.Medscape eMedicine+1Scleral contact lenses for visual rehabilitationScleral lenses are large, rigid lenses that vault over the cornea and hold a fluid reservoir against it. In some patients with irregular or scarred corneas due to endothelial dystrophy, these lenses can create a smooth optical surface and give much clearer vision than glasses. They must be fitted by a specialist and monitored to avoid hypoxia or pressure on the cornea.ScienceDirect+1Frequent blinking and screen-time breaksLong periods of screen use reduce blink rate and can dry the ocular surface. Following a simple “20-20-20” rule (every 20 minutes, look 20 feet away for 20 seconds and blink fully) helps spread tears more evenly and may reduce burning and gritty feeling in patients with endothelial disease and associated dry eye.Medscape eMedicine+1Good eyelid hygieneCleaning the eyelid margins daily with a warm, damp cloth or commercial lid wipes can remove oil and debris that might irritate the corneal surface. Healthy lids and meibomian glands support a stable tear film, which is important for comfort and for protecting the already stressed cornea in endothelial dystrophy.FDA Access Data+1Optimizing sleep and body positionSome patients notice more swelling in the eye they sleep on. Using a higher pillow, avoiding sleeping face-down, and sometimes changing the side you sleep on may reduce morning asymmetry in swelling. Good sleep patterns also help overall eye comfort and healing, as the cornea recovers overnight.aao.org+1Hydration with adequate water intakeStaying well hydrated keeps the whole body, including the ocular surface, healthier. While drinking extra water does not cure endothelial dystrophy, avoiding dehydration can support tear production and general eye comfort. It is especially important in hot climates and for patients who take diuretics or other medicines that can dry the body.NCBI+1Control of systemic diseases (diabetes, hypertension)Conditions such as diabetes and high blood pressure can worsen eye health and may speed up corneal damage in some patients. Keeping blood sugar and blood pressure in the target range recommended by your doctor can indirectly help protect the cornea and reduce the risk of other eye complications like diabetic retinopathy or hypertensive retinopathy.NCBI+1Stopping smoking and avoiding second-hand smokeSmoking is a known risk factor for more severe Fuchs endothelial dystrophy and poorer results after corneal transplant. Quitting smoking and avoiding smoky places may slow disease progression, improve surgery outcomes, and support overall eye and body health. Support programs and nicotine replacement can help patients stop safely.NCBI+1Regular eye examinations and monitoringSeeing an ophthalmologist regularly allows the doctor to monitor corneal thickness, cell counts, and vision over time. Early changes can be detected before severe symptoms appear, and treatment can be adjusted step-by-step. This reduces the risk of sudden visual loss and helps plan the best timing for surgery when needed.aao.org+1Use of preservative-free artificial tearsAlthough technically these are “products,” simple lubricating drops without medications are often counted as non-pharmacological support. Preservative-free tears help wash away debris, smooth the surface, and reduce burning or gritty sensations without adding drugs that can irritate the cornea. They can be used many times per day as advised.Medscape eMedicine+1Avoiding eye rubbingRubbing the eyes can mechanically stress the already fragile corneal tissue. It may worsen swelling and increase the risk of micro-trauma or scarring. Patients should be taught gentle ways to wipe tears or itch, such as pressing lightly on the eyelid with a clean tissue rather than rubbing side to side.aao.org+1Managing contact lens wear carefullyIf a patient already wears contact lenses for other reasons, the eye doctor may limit wear time or change the lens type. Over-wearing lenses can reduce oxygen delivery to the cornea and worsen swelling. Careful hygiene, regular lens breaks, and follow-up visits reduce the risk of infection and additional damage.Medscape eMedicine+1Low-vision aids and lighting adjustmentsFor people with permanently reduced vision who are not ready or not suitable for surgery, low-vision aids (magnifiers, special lamps, large-print materials) can help them continue reading, working, and doing daily tasks. Adjusting room lighting and reducing glare from shiny surfaces also makes living with the disease easier.NCBI+1Psychological and social supportLiving with a chronic eye disease can cause anxiety, sadness, or fear of blindness. Support from family, counselors, or patient groups can help people cope. Understanding that effective treatments and surgeries exist can reduce worry and improve quality of life, even if vision is currently reduced.Manchester NHS Trust+1Education about disease and surgery optionsClear education about dystrophy of the corneal endothelium, the possible course of the disease, and all treatment options gives patients a sense of control. When people understand what hypertonic drops, contact lenses, or surgeries do, they can take part in shared decision-making and choose the timing of interventions that best fits their life.aao.org+1Drug treatmentsImportant: All medicines should be used only under the supervision of an eye specialist. Doses below are typical examples from FDA labels or clinical practice, but your doctor may choose something different for your situation. Never start, stop, or change any medicine on your own.Hypertonic sodium chloride 5% eye dropsHypertonic saline drops draw extra water out of the swollen cornea by osmosis and are a main early treatment for Fuchs endothelial dystrophy. FDA monographs list sodium chloride 2–5% as an over-the-counter hypertonicity agent for ophthalmic use. Typical use is one drop in the affected eye several times a day and at bedtime, but schedules vary. Side effects include temporary burning or stinging.Medscape eMedicine+1Hypertonic sodium chloride 5% eye ointment at nightA thicker 5% sodium chloride ointment can be used before sleep to keep a strong hypertonic effect on the cornea overnight, helping reduce morning swelling and blur. It slowly melts over the eye surface. It can cause temporary foggy vision and mild irritation after application, so it is usually used at bedtime only.Medscape eMedicine+1Preservative-free lubricating artificial tearsAlthough often considered supportive rather than “drug therapy,” many artificial tear formulations are regulated as ophthalmic drug products. They use polymers such as carboxymethylcellulose or hyaluronic acid to coat and protect the cornea, reduce friction from blinking, and improve comfort. They are usually used 4–6 times daily or as needed. Side effects are usually mild, such as brief blur.FDA Access Data+1Topical sodium hyaluronate eye dropsHyaluronic acid–based lubricants bind water and stay longer on the eye surface, improving comfort and sometimes visual quality. They support epithelial healing but do not fix the endothelial pump itself. Typical dosing is one drop 3–6 times daily. Side effects are mild, mainly transient blur or rare allergy.ScienceDirect+1Topical corticosteroid drops (for inflammation when indicated)Short courses of eye steroid drops such as prednisolone acetate may be used after surgery or when there is associated inflammation. They reduce swelling and immune reactions but must be used with great care because they can raise eye pressure and increase infection risk. Doses and tapering schedules are individualized by the ophthalmologist.aaojournal.org+1Netarsudil 0.02% (Rhopressa) eye dropsNetarsudil is a rho-kinase inhibitor approved by the FDA to lower intraocular pressure in open-angle glaucoma and ocular hypertension. Typical dosing is one drop in the affected eye in the evening. Research suggests ROCK inhibitors may also support corneal endothelial cell function in some settings, so they are being studied and sometimes used off-label in endothelial disease; side effects include redness and corneal changes.FDA Access Data+2FDA Access Data+2Netarsudil/latanoprost combination (Rocklatan)This fixed-dose combination contains netarsudil with latanoprost and is approved for reducing elevated intraocular pressure. It may be used when glaucoma co-exists with corneal endothelial dystrophy, to safely control pressure and protect remaining vision. It is given once daily at night. Side effects include redness, pigmentation changes, and eyelash growth from the prostaglandin component.FDA Access Data+2FDA Access Data+2Latanoprost eye dropsLatanoprost is a prostaglandin analogue that increases fluid outflow from the eye and is approved for lowering intraocular pressure in glaucoma and ocular hypertension. When a patient with endothelial dystrophy also has high eye pressure, controlling pressure can protect the cornea and optic nerve. Usual dosing is one drop at night; side effects include redness, darkening of iris color, and eyelash changes.FDA Access Data+1Timolol maleate eye dropsTimolol is a beta-blocker eye drop that lowers eye pressure by reducing fluid production inside the eye. It is widely used for glaucoma and may be prescribed if an endothelial dystrophy patient also has ocular hypertension. It is typically used once or twice daily. Side effects can include slow heart rate, low blood pressure, and breathing problems in susceptible patients, so systemic health must be checked.FDA Access Data+1Dorzolamide or brinzolamide eye dropsThese carbonic anhydrase inhibitor drops lower intraocular pressure by decreasing fluid formation inside the eye. They may be added when a single medicine is not enough to control pressure. In some patients with corneal problems, they can slightly worsen corneal edema, so ophthalmologists use them cautiously and monitor the cornea closely.FDA Access Data+1Brimonidine tartrate eye dropsBrimonidine is an alpha-2 agonist that lowers eye pressure through reduced production and increased outflow of aqueous humor. It may be used as an add-on drop in glaucoma associated with corneal dystrophy. Typical dosing is two or three times daily. Side effects include eye redness, fatigue, and dry mouth.FDA Access Data+1Lifitegrast (Xiidra) 5% eye dropsLifitegrast is FDA-approved for dry eye disease. In patients with corneal endothelial dystrophy who also have inflammatory dry eye, lifitegrast can reduce surface inflammation and improve comfort, which may indirectly protect the compromised cornea. Standard dosing is one drop twice daily. Common side effects include burning on instillation, taste disturbance, and blurred vision.FDA Access Data+1Topical cyclosporine A eye dropsCyclosporine eye drops are used for chronic dry eye by decreasing surface inflammation and increasing tear production. When dry eye co-exists with endothelial disease, cyclosporine can help stabilize the tear film, which supports the health of the corneal surface. Side effects include burning and stinging when first started, and benefits may take months to appear.FDA Access Data+1Topical non-steroidal anti-inflammatory drops (NSAIDs, short term)Short courses of NSAID eye drops may be used after surgery for pain control. They work by blocking prostaglandins that cause inflammation and pain. However, overuse can slow corneal healing or even cause corneal melting in rare cases, so they are used carefully and not as long-term treatment for dystrophy itself.aaojournal.org+1Hyperosmotic systemic agents (rare, hospital use)In severe acute corneal edema combined with very high eye pressure, systemic hyperosmotic agents like intravenous mannitol or oral glycerol may be used in hospital to rapidly lower intraocular pressure. They work by drawing fluid out of the eye. This is an emergency-level treatment, not a routine therapy for dystrophy, and has important systemic side effects like dehydration and heart stress.Unbound Medicine+1Antibiotic eye drops or ointments (for infection risk)When the corneal surface is broken due to blisters, there is a higher risk of infection. Short courses of antibiotic drops or ointments may be prescribed to prevent or treat bacterial keratitis. Choice of antibiotic depends on local practice. Side effects can include allergy and, with overuse, resistance. They do not treat the dystrophy itself, only infection risk.Medscape eMedicine+1Mydriatic or cycloplegic drops for pain (short-term)In some painful situations, drops that temporarily dilate the pupil and relax the iris muscle are used to ease ciliary spasm and pain. These are more common in other corneal diseases but may be used briefly in severe endothelial dystrophy flare-ups. They can blur near vision and increase light sensitivity, so they are used carefully.Unbound Medicine+1Post-operative steroid-antibiotic combinationsAfter endothelial keratoplasty or other corneal surgery, combined steroid-antibiotic drops are often used to control inflammation and prevent infection simultaneously. Regimens vary widely, and doses are tapered over weeks to months based on graft clarity and pressure checks. Side effects include raised intraocular pressure and cataract risk with long-term steroid use.aaojournal.org+1Glaucoma fixed-combination dropsVarious fixed-combination drops (for example, timolol with dorzolamide, or timolol with brimonidine) may be prescribed to simplify multiple-drug glaucoma treatment in patients who also have corneal endothelial dystrophy. Fewer bottles can improve adherence but may increase the load of preservatives, so the doctor balances benefits and risks.FDA Access Data+1Investigational topical agents for endothelial protectionEmerging research focuses on topical drugs that protect or regenerate endothelial cells, such as ROCK-inhibitor-based therapies, gene therapies, and antioxidant complexes like ubiquinol-cyclodextrin formulations. These are mostly in clinical trials or early clinical use and are not yet standard care, but they hold promise for future non-surgical treatment of corneal endothelial dystrophies.ScienceDirect+2Review of Contact Lenses+2Dietary molecular supplementsOmega-3 fatty acids (fish oil, algae oil)Omega-3 fatty acids support the oily layer of the tear film, reduce ocular surface inflammation, and may improve dry eye symptoms that often co-exist with corneal endothelial dystrophy. Typical supplemental doses in adults are around 1000–2000 mg combined EPA and DHA per day, but patients should follow medical advice, especially if they take blood thinners. The mechanism includes anti-inflammatory effects and improved tear quality.Vitamin C (ascorbic acid)Vitamin C is a strong antioxidant that helps collagen production and tissue repair, including in the cornea. A typical dietary supplement dose is 500–1000 mg per day, unless restricted by a doctor. It helps neutralize free radicals produced by UV light and oxidative stress, which are thought to contribute to endothelial cell damage.Vitamin E (alpha-tocopherol)Vitamin E is a fat-soluble antioxidant that protects cell membranes, including those of corneal and endothelial cells, from oxidative damage. Doses of 100–400 IU per day are common in supplements, but high doses should be supervised because of bleeding risk. By stabilizing cell membranes, vitamin E may support overall eye health in chronic corneal diseases.Lutein and zeaxanthinThese carotenoids concentrate mainly in the retina but act as blue-light filters and antioxidants in the entire eye. Supplements often provide 10–20 mg lutein plus 2–4 mg zeaxanthin daily. They may help reduce oxidative stress from light exposure and support long-term ocular health, complementing other treatments for corneal dystrophy.Coenzyme Q10 (ubiquinone/ubiquinol)CoQ10 is involved in mitochondrial energy production and acts as an antioxidant. Experimental topical and oral CoQ10 formulations are being studied for protecting corneal endothelial cells from oxidative stress. Typical oral doses range from 100–300 mg daily. It may support cellular energy and resistance to oxidative damage, but patients should discuss use with their doctors.Review of Contact Lenses+1Alpha-lipoic acidAlpha-lipoic acid is an antioxidant that works in both water and fat environments and can regenerate other antioxidants such as vitamin C and E. Common supplement doses are 300–600 mg per day. It is often used in diabetic neuropathy and may help reduce oxidative stress throughout the body, indirectly supporting delicate corneal tissues.ZincZinc is essential for many enzymes in the eye and immune system. Moderate supplemental doses (e.g., 10–25 mg elemental zinc per day) may support wound healing and antioxidant defenses. Excess zinc can cause nausea and copper deficiency, so balanced intake and medical guidance are important.SeleniumSelenium is a component of antioxidant enzymes like glutathione peroxidase, which protect against oxidative damage. Low-dose supplements (50–100 mcg per day) may support ocular and systemic antioxidant capacity. High doses can be toxic, so patients must avoid self-prescribing large amounts.N-acetylcysteine (NAC)NAC is a precursor to glutathione, a major cellular antioxidant. Oral NAC at doses such as 600–1200 mg daily is used in other conditions to reduce oxidative stress. By boosting glutathione, NAC may help protect tissues, including the cornea, from oxidative injury, though direct evidence in endothelial dystrophy is still limited.Multivitamin with balanced micronutrientsFor many patients, a simple, once-daily multivitamin with appropriate levels of vitamins A, C, E, B-complex, zinc, selenium, and other micronutrients can support overall eye and body health. It helps fill dietary gaps and may assist healing and immune function without megadoses of any single nutrient. Patients with kidney or liver disease need individualized advice.Immunity-booster, regenerative, and stem-cell–related therapiesAutologous serum eye dropsThese drops are made from the patient’s own blood serum, diluted and sterilized, then used as eye drops. They contain growth factors, vitamins, and proteins similar to natural tears and can support corneal surface healing, especially when the epithelium is damaged. They do not directly cure endothelial dystrophy but improve the surface environment, which is critical for comfort and vision.Umbilical cord serum or platelet-rich plasma (PRP) eye dropsIn some centers, drops derived from umbilical cord blood or platelet-rich plasma are used when autologous serum is not suitable. These biologic drops provide concentrated growth factors that stimulate epithelial repair and may reduce pain and dryness. They remain specialized treatments and must be prepared under strict sterile conditions.Experimental cultured corneal endothelial cell therapyResearchers are developing techniques to grow corneal endothelial cells in the laboratory and inject or place them onto the back of the cornea, sometimes with a ROCK inhibitor to help them attach. Early studies show promising recovery of corneal clarity in some patients with endothelial failure, but these methods are still largely experimental and not yet widely available.ScienceDirect+1Gene-based and RNA-based therapies (research stage)For genetic forms of endothelial dystrophy, such as some Fuchs dystrophy variants, scientists are exploring gene editing (for example CRISPR) and antisense oligonucleotide therapies to silence or correct harmful mutations. These approaches aim to protect or restore endothelial cell function at the genetic level. At present they are only in research or clinical trials, not routine care.ScienceDirect+1Systemic immune-modulating drugs (rare situations)In unusual cases where corneal endothelial problems are linked to systemic autoimmune disease, systemic immunosuppressive drugs such as oral steroids, methotrexate, or biologics may be used under specialist supervision. They damp down harmful immune attacks on tissues across the body but carry significant side effects like infection risk and organ toxicity, so they are used cautiously.Future stem-cell–derived corneal endothelial replacementsStem-cell technologies aim to produce unlimited healthy endothelial cells from pluripotent stem cells. These could one day be used to create ready-made grafts or injectable cell suspensions, reducing dependence on donor corneas. Research is active but still in the early to mid stages, and long-term safety and effectiveness must be confirmed before routine use.ScienceDirect+1Surgical treatmentsDescemet membrane endothelial keratoplasty (DMEK)DMEK is currently considered the gold-standard surgery for many patients with Fuchs endothelial dystrophy. The surgeon removes the diseased Descemet membrane and endothelium from the patient and replaces it with a thin layer of healthy donor endothelium and Descemet membrane. Vision often recovers quickly with good optical quality because the cornea’s front layers are preserved.PubMed+1Descemet stripping automated endothelial keratoplasty (DSAEK/DSEK)In DSAEK, the surgeon transplants a slightly thicker disc of donor tissue containing endothelium, Descemet membrane, and a thin slice of stroma. It is technically easier than DMEK and widely available. Visual recovery is usually very good but may be slightly less sharp than DMEK because of the extra stromal layer. It is often used in more complex eyes.aaojournal.org+1Descemet stripping only (DSO/Descemetorhexis without graft)In carefully selected patients with central Fuchs changes and good peripheral endothelium, the surgeon may simply remove the central diseased Descemet membrane without placing a graft. Healthy peripheral cells can migrate to cover the center. ROCK-inhibitor drops are sometimes used afterward to support healing. This approach may avoid donor tissue but is suitable only for specific cases.ResearchGate+1Penetrating keratoplasty (full-thickness corneal transplant)In this older technique, the surgeon removes a round full-thickness piece of the patient’s cornea and replaces it with a full-thickness donor cornea. It is now mainly used when there is deep scarring or when lamellar techniques are not possible. Recovery is slower, vision can fluctuate, and there is more risk of rejection and astigmatism than with DMEK or DSAEK.cornealdystrophyfoundation.org+1Combined cataract and endothelial surgery (“triple” procedure)Many patients with Fuchs dystrophy also have cataract. In such cases, surgeons may perform cataract extraction, intraocular lens implantation, and DMEK or DSAEK in one combined operation. This “triple” procedure can restore both corneal clarity and lens clarity at once, reducing the need for multiple surgeries and helping vision recover more quickly overall.PubMed+1Prevention and lifestyle tipsEven though the underlying genetic tendency cannot be fully prevented, lifestyle and eye-care habits can reduce symptom severity and protect vision. Helpful steps include not smoking, controlling diabetes and blood pressure, using UV-blocking sunglasses outdoors, avoiding eye rubbing, keeping eyelids clean, managing screen time and dry environments, staying well hydrated, attending regular eye checks, following all drop and ointment schedules carefully, and seeking immediate care for sudden pain or vision changes.NCBI+2aao.org+2When to see doctorsYou should see an eye doctor (preferably an ophthalmologist) if you notice chronic blurred or hazy vision, especially in the morning, increased glare around lights, or a family history of Fuchs or other corneal dystrophies. You should seek urgent or emergency care if you develop sudden severe eye pain, rapid worsening of vision, many new light halos, redness with discharge, or if your eye feels like it has a cut or foreign body after trauma or surgery. Early and regular care greatly improves the chance of keeping good vision.aao.org+1What to eat and what to avoidA diet rich in colorful vegetables, fruits, whole grains, lean proteins, and healthy fats supports overall eye health. Foods high in omega-3 fats (fatty fish like salmon, sardines, or plant sources like flaxseed and chia), citrus fruits, berries, leafy greens (spinach, kale), nuts, and seeds provide antioxidants and anti-inflammatory nutrients that may help protect delicate eye tissues. Drinking enough water keeps the body and tear film well hydrated.It is wise to limit very salty foods, heavily processed snacks, and sugary drinks, as they can worsen systemic problems like high blood pressure and diabetes, which affect the eyes. Excess alcohol and smoking should be avoided because they increase oxidative stress and vascular damage. People with kidney, heart, or other chronic diseases should follow specific nutrition plans given by their doctors or dietitians.NCBI+1Frequently asked questionsIs dystrophy of the corneal endothelium the same as Fuchs dystrophy?Fuchs endothelial corneal dystrophy is the most common type of corneal endothelial dystrophy, especially in older adults, but there are other types as well. Many treatment principles are similar because all involve damage to the inner pump cells of the cornea.NCBI+1Can this disease make me blind?Severe untreated disease can cause major vision loss due to long-standing corneal clouding and scarring, but today many effective treatments and surgeries exist. With regular follow-up and timely interventions such as DMEK or DSAEK, most patients can maintain functional vision.PubMed+1Does everyone with dystrophy of the corneal endothelium need surgery?No. Some people have very mild disease and only need monitoring and simple measures like hypertonic drops and lifestyle changes. Surgery is usually considered when blurred vision or pain affects daily life and cannot be controlled with non-surgical options.Medscape eMedicine+1Can glasses or contact lenses cure my dystrophy?Glasses and special contact lenses can improve how clearly images reach the retina and can reduce pain, but they do not repair or replace the diseased endothelial cells. Only surgeries or future regenerative therapies can restore the pump function of this cell layer.ScienceDirect+1Is this disease inherited?Many corneal endothelial dystrophies, especially Fuchs dystrophy, have a genetic component, and family members may be affected. However, the exact pattern of inheritance can vary, and environmental factors also play a role. Genetic counseling may be useful in some families.NCBI+1Will eye drops alone be enough for my whole life?For some people with mild disease, drops and non-pharmacological measures may be enough for a long time. In others, the disease slowly progresses, and eventually surgery becomes the best way to improve vision. Your ophthalmologist will track your cornea and help you decide on the right time for surgery if needed.Medscape eMedicine+1How long does recovery from DMEK or DSAEK take?Many patients notice improved vision within weeks after endothelial keratoplasty, but full recovery can take several months. DMEK often gives the sharpest vision, while DSAEK may recover a little more slowly. Regular post-operative visits and correct use of drops are essential for success.PubMed+2aaojournal.org+2Can surgery fail or need to be repeated?Yes, there is always a risk that a corneal graft may fail, detach, reject, or lose too many cells over time. In such cases, additional treatments or repeat transplants may be required. However, success rates for modern endothelial keratoplasty are generally high when performed by experienced surgeons.aaojournal.org+1Is there any way to stop the genes causing this disease?At present, there is no approved way to change the genes that predispose to endothelial dystrophy. Research into gene and RNA-based therapies is active and offers hope for future treatments, but these are not yet available outside clinical trials.ScienceDirect+1Can lifestyle changes really make a difference?While lifestyle changes cannot change the underlying gene problem, they can support overall eye health, reduce other stresses on the cornea, and improve comfort. Not smoking, protecting eyes from UV light, keeping medical conditions under control, and following your treatment plan make a meaningful difference.NCBI+1Is it safe to use over-the-counter eye drops?Some over-the-counter lubricating drops and hypertonic saline drops are helpful, but others (especially “get the red out” vasoconstrictor drops) can cause rebound redness or irritation. Always ask your eye doctor which products are safe and how often you can use them.FDA Access Data+1Can I wear contact lenses after corneal transplant?Many patients can use soft or rigid contact lenses after their cornea has healed if needed to refine vision. The timing and type of lens depend on graft stability and surface shape. Your surgeon will let you know when it is safe to consider contact lenses.aaojournal.org+1Is it okay to have cataract surgery if I have endothelial dystrophy?Yes, but it needs special planning. Cataract surgery can stress the endothelium, so surgeons may use gentler techniques or combine cataract surgery with DMEK/DSAEK in a triple procedure. A careful pre-operative assessment is essential to choose the best strategy.PubMed+1Can children get dystrophy of the corneal endothelium?Most endothelial dystrophies, like Fuchs dystrophy, appear in mid-to-late adult life, but some rare hereditary dystrophies can show in childhood. Any child with unexplained corneal clouding or reduced vision should be evaluated by a pediatric ophthalmologist for proper diagnosis.NCBI+1What is the most important thing I can do right now?The most important step is to have a full eye exam with an ophthalmologist, follow the treatment plan carefully, and keep all follow-up appointments. Ask questions until you feel you understand your condition. With modern non-pharmacological therapies, eye drops, supplements, and advanced surgeries, many people with dystrophy of the corneal endothelium can continue to live active, independent lives.aao.org+1Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.The article is written by Team RxHarun and reviewed by the Rx Editorial Board MembersLast Updated: December 21, 2025.PDF Documents For This Disease ConditionRare Diseases and Medical Genetics.[rxharun.com] i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com] the-UK-rare-diseases-framework.[rxharun.com] National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com] History of rare diseases and their genetic.[rxharun.com] health-care-and-rare-disorders.[rxharun.com] Rare Disease Registries.[rxharun.com] autoimmune-Rare-Genetic-Diseases.[rxharun.com] Rare Genetic Diseases.[rxharun.com] rare-disease-day.[rxharun.com] Rare_Disease_Drugs_e.[rxharun.com] fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com] rare-and-inherited-disease-eligibility-criteria.[rxharun.com] FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]FDA-rare-disease-lists.[rxharun.com] 30212783fnl_Rare Disease.[rxharun.com] FDA-rare-disease-list.[rxharun.com] List of rare disease.[rxharun.com] Genome Res.-2025-Steyaert-755-68.[rxharun.com] uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com] PIIS2949774424010355.[rxharun.com] hidden-costs-2016.[rxharun.com] B156_CONF2-en.[rxharun.com] IRDiRC_State-of-Play-2018_Final.[rxharun.com] IRDR_2022Vol11No3_pp96_160.[rxharun.com] from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com] Rare disease fda.[rxharun.com] England-Rare-Diseases-Action-Plan-2022.[rxharun.com] SCRDAC 2024 Report.[rxharun.com] CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com] Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com] rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com] ENG_White paper_A4_Digital_FINAL.[rxharun.com] UK_Strategy_for_Rare_Diseases.[rxharun.com] MalaysiaRareDiseaseList.[rxharun.com] EURORDISCARE_FULLBOOKr.[rxharun.com] EMHJ_1999_5_6_1104_1113.[rxharun.com] national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com] be-counted-052722-WEB.[rxharun.com] RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com] genomic-analysis-of-rare-disease-brochure.[rxharun.com] List-of-rare-diseases.[rxharun.com] RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com] rdnumbers.[rxharun.com] .Rare disease atoz .[rxharun.com] EmanPublisher_12_5830biosciences-.[rxharun.com]Referenceshttps://www.ncbi.nlm.nih.gov/books/NBK208609/https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/https://rarediseases.org/rare-diseases/https://rarediseases.info.nih.gov/diseaseshttps://en.wikipedia.org/w/index.php?title=Category:Rare_diseaseshttps://en.wikipedia.org/wiki/List_of_genetic_disordershttps://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disordershttps://medlineplus.gov/genetics/condition/https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.fda.gov/patients/rare-diseases-fdahttps://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-programhttps://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltexthttps://www.ncbi.nlm.nih.gov/mesh?https://www.rarediseasesinternational.org/working-with-the-who/https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7https://www.rarediseasesnetwork.org/https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-diseasehttps://www.raregenomics.org/rare-disease-listhttps://www.astrazeneca.com/our-therapy-areas/rare-disease.htmlhttps://bioresource.nihr.ac.uk/rarehttps://www.roche.com/solutions/focus-areas/neuroscience/rare-diseaseshttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomicshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026https://wikicure.fandom.com/wiki/Rare_Diseaseshttps://www.wikidoc.org/index.php/List_of_genetic_disordershttps://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/https://www.orpha.net/en/disease/listhttps://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspxhttps://ojrd.biomedcentral.com/https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_enhttps://bioportal.bioontology.org/ontologies/ORDOhttps://www.orpha.net/en/disease/listhttps://www.fda.gov/industry/medical-products-rare-diseases-and-conditionshttps://www.gao.gov/products/gao-25-106774https://www.gene.com/partners/what-we-are-looking-for/rare-diseaseshttps://www.genome.gov/For-Patients-and-Families/Genetic-Disordershttps://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/https://my.clevelandclinic.org/health/diseases/21751-genetic-disordershttps://globalgenes.org/rare-disease-facts/https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nordhttps://byjus.com/biology/genetic-disorders/https://www.cdc.gov/genomics-and-health/about/genetic-disorders.htmlhttps://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/https://www.thegenehome.com/basics-of-genetics/disease-exampleshttps://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/https://www.pfizerclinicaltrials.com/our-research/rare-diseaseshttps://clinicaltrials.gov/ct2/results?recrshttps://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdfhttps://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239https://www.nibib.nih.gov/https://www.nei.nih.gov/https://oxfordtreatment.com/https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/https://www.nccih.nih.gov/healthhttps://catalog.ninds.nih.gov/https://www.aarda.org/diseaselist/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheetshttps://www.nibib.nih.gov/https://www.nia.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.nimh.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.niehs.nih.gov/https://www.nimhd.nih.gov/https://www.nhlbi.nih.gov/health-topicshttps://obssr.od.nih.gov/.https://www.nichd.nih.gov/health/topicshttps://rarediseases.info.nih.gov/diseaseshttps://beta.rarediseases.info.nih.gov/diseaseshttps://orwh.od.nih.gov/ SaveSavedRemoved 0 PreviousChandler Syndrome NextEndothelial Corneal Dystrophy Related ArticlesAdded to wishlistRemoved from wishlist 0 Channelopathy-Associated Congenital Insensitivity to Pain (CIP)Added to wishlistRemoved from wishlist 0 Posterior Membrane Corneal DystrophyAdded to wishlistRemoved from wishlist 0 Endothelial Corneal DystrophyAdded to wishlistRemoved from wishlist 0 Chandler Syndrome
Added to wishlistRemoved from wishlist 0 Channelopathy-Associated Congenital Insensitivity to Pain (CIP)